Zusduri Kit
NDC 72493-106
Product Information
Zusduri (mitomycin) is a NDA-approved product labeled by Urogen Pharma, Inc. Mitomycin is used to treat various types of cancer (such as stomach/pancreas cancer). It is supplied as a kit. This product entry covers the primary NDC 72493-106 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 72493-106?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- MITOMYCIN (UNII: 50SG953SK6)
- MITOMYCIN (UNII: 50SG953SK6) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- MANNITOL (UNII: 3OWL53L36A)
- POLOXAMER 407 (UNII: TUF2IVW3M2)
- POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)
- HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO)
- WATER (UNII: 059QF0KO0R)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 2719766 - mitoMYcin 40 MG Powder for Intravesical Solution
- RxCUI: 2719766 - mitomycin 40 MG Powder for Intravesical Solution
- RxCUI: 2719771 - Zusduri 40 MG Powder for Intravesical Solution
- RxCUI: 2719771 - mitomycin 40 MG Powder for Intravesical Solution [Zusduri]
* Please review the full disclaimer at the bottom of this page.